Loading...
Chromatin remodeling ATPase BRG1 and PTEN are synthetic lethal in prostate cancer
Loss of phosphatase and tensin homolog (PTEN) represents one hallmark of prostate cancer (PCa). However, restoration of PTEN or inhibition of the activated PI3K/AKT pathway has shown limited success, prompting us to identify obligate targets for disease intervention. We hypothesized that PTEN loss m...
Saved in:
| Published in: | J Clin Invest |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
American Society for Clinical Investigation
2019
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6355211/ https://ncbi.nlm.nih.gov/pubmed/30496141 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI123557 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|